Level Chart

Level Chart

Basic Info

Regeneron Pharmaceuticals (REGN) - Net Product Sales Revenue is at a current level of 1.642B, up from 1.534B last quarter and up from 1.631B one year ago. This is a change of 7.03% from last quarter and 0.70% from one year ago.

Region United States
Source Fiscal.ai

Data provided via Fiscal.ai

Stats

Last Value 1.642B
Latest Period Jun 2026
Last Updated Jul 31 2026, 10:02 EDT
Next Release Oct 28 2026, 08:30 EDT (E)
Average Growth Rate 23.27%
Value from Last Quarter 1.534B
Change from Last Quarter 7.03%
Value from 1 Year Ago 1.631B
Change from 1 Year Ago 0.70%
Frequency Quarterly
Unit USD
Adjustment N/A
Download Source File

Historical Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 1.642B
March 31, 2026 1.534B
December 31, 2025 1.675B
September 30, 2025 1.588B
June 30, 2025 1.631B
March 31, 2025 1.416B
December 31, 2024 2.003B
September 30, 2024 1.946B
June 30, 2024 1.919B
March 31, 2024 1.761B
December 31, 2023 1.852B
September 30, 2023 1.786B
June 30, 2023 1.772B
March 31, 2023 1.668B
Date Value
December 31, 2022 1.699B
September 30, 2022 1.801B
June 30, 2022 1.754B
March 31, 2022 1.639B
December 31, 2021 3.975B
September 30, 2021 2.280B
June 30, 2021 4.138B
March 31, 2021 1.724B
December 31, 2020 1.622B
September 30, 2020 1.482B
June 30, 2020 1.227B
March 31, 2020 1.237B
December 31, 2019 1.286B

Basic Info

Regeneron Pharmaceuticals (REGN) - Net Product Sales Revenue is at a current level of 1.642B, up from 1.534B last quarter and up from 1.631B one year ago. This is a change of 7.03% from last quarter and 0.70% from one year ago.

Region United States
Source Fiscal.ai

Data provided via Fiscal.ai

Stats

Last Value 1.642B
Latest Period Jun 2026
Last Updated Jul 31 2026, 10:02 EDT
Next Release Oct 28 2026, 08:30 EDT (E)
Average Growth Rate 23.27%
Value from Last Quarter 1.534B
Change from Last Quarter 7.03%
Value from 1 Year Ago 1.631B
Change from 1 Year Ago 0.70%
Frequency Quarterly
Unit USD
Adjustment N/A
Download Source File

Related Securities

Symbol Name Change %
REGN Regeneron Pharmaceuticals, Inc. -1.87%